KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Non-cash Items (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Non-cash Items for 13 consecutive years, with $6.3 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 94.35% to $6.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Dec 2025, down 94.35% year-over-year, with the annual reading at $6.3 million for FY2025, 94.35% down from the prior year.
  • Non-cash Items for Q4 2025 was $6.3 million at Xenon Pharmaceuticals, down from $6.4 million in the prior quarter.
  • The five-year high for Non-cash Items was $200.1 million in Q4 2023, with the low at $2.8 million in Q1 2021.
  • Average Non-cash Items over 5 years is $31.9 million, with a median of $5.6 million recorded in 2024.
  • The sharpest move saw Non-cash Items surged 246.0% in 2021, then tumbled 94.35% in 2025.
  • Over 5 years, Non-cash Items stood at $105.4 million in 2021, then surged by 39.67% to $147.2 million in 2022, then soared by 35.94% to $200.1 million in 2023, then tumbled by 44.43% to $111.2 million in 2024, then crashed by 94.35% to $6.3 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $6.3 million, $6.4 million, and $6.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.